Healthcare provider profile · identity verified

Daniel Martin Mince, MD

Allopathic & Osteopathic Physicians|Internal Medicine · FORT PAYNE, AL · NPI 1073568812

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Daniel Martin Mince, MD received $96.83 in general payments during 2025 across 5 reported records.

Sumitomo Pharma America, Inc. accounted for 40.8% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 36 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Trulicity by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 223 claims for Eliquis by this doctor in 2024.

PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Paxlovid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$96.83

5 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Sumitomo Pharma America, Inc.	Unresolved — no canonical attribution shown	$39.54	40.8%	2	2025
PFIZER INC.	Unresolved — no canonical attribution shown	$37.30	38.5%	2	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$19.99	20.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$96.83	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
GEMTESA Normalized: gemtesa	Drug	Sumitomo Pharma America, Inc.	$39.54	2	2025
Source payment records 2025-02-12 · Sumitomo Pharma America, Inc. · $18.11 · Open Payments source 2025-05-19 · Sumitomo Pharma America, Inc. · $21.43 · Open Payments source
NURTEC ODT Normalized: nurtec odt	Drug	PFIZER INC.	$37.30	2	2025
Source payment records 2025-05-28 · PFIZER INC. · $21.49 · Open Payments source 2025-08-19 · PFIZER INC. · $15.81 · Open Payments source
ZAVZPRET Normalized: zavzpret	Drug	PFIZER INC.	$37.30	2	2025
Source payment records 2025-05-28 · PFIZER INC. · $21.49 · Open Payments source 2025-08-19 · PFIZER INC. · $15.81 · Open Payments source
JARDIANCE Normalized: jardiance	Drug	Lilly USA, LLC	$19.99	1	2025
Source payment records 2025-10-28 · Lilly USA, LLC · $19.99 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	93	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	93	14
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	36	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	17	suppressed by CMS
PFIZER INC. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063	Eliquis · 2024 Exact normalized brand match · 1 Part D row	223	38
PFIZER INC. Exact reporting entity; no affiliate inference	2025	PAXLOVID open payments reported associated product	CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432	Paxlovid · 2024 Exact normalized brand match · 1 Part D row	12	12

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	955	197
Losartan Potassium	Losartan Potassium	702	174
Gabapentin	Gabapentin	655	108
Amlodipine Besylate	Amlodipine Besylate	631	144
Lisinopril	Lisinopril	535	114
Trazodone Hcl	Trazodone Hcl	490	72
Alprazolam	Alprazolam	473	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	470	71
Metformin Hcl	Metformin Hcl	449	110
Montelukast Sodium	Montelukast Sodium	415	94
Omeprazole	Omeprazole	409	95
Rosuvastatin Calcium	Rosuvastatin Calcium	406	93
Pantoprazole Sodium	Pantoprazole Sodium	402	90
Atorvastatin Calcium	Atorvastatin Calcium	392	97
Hydrochlorothiazide	Hydrochlorothiazide	335	80
Meloxicam	Meloxicam	318	69
Metoprolol Succinate	Metoprolol Succinate	317	77
Carvedilol	Carvedilol	287	59
Zolpidem Tartrate	Zolpidem Tartrate	272	32
Pravastatin Sodium	Pravastatin Sodium	267	60
Furosemide	Furosemide	249	64
Potassium Chloride	Potassium Chloride	248	56
Glipizide	Glipizide	226	46
Eliquis	Apixaban	223	38
Tamsulosin Hcl	Tamsulosin Hcl	209	44
Escitalopram Oxalate	Escitalopram Oxalate	208	46
Duloxetine Hcl	Duloxetine Hcl	203	45
Pregabalin	Pregabalin	188	30
Diclofenac Sodium	Diclofenac Sodium	180	47
Azithromycin	Azithromycin	179	136
Ozempic	Semaglutide	172	26
Fluticasone Propionate	Fluticasone Propionate	170	61
Sucralfate	Sucralfate	170	45
Baclofen	Baclofen	168	31
Buspirone Hcl	Buspirone Hcl	160	31
Donepezil Hcl	Donepezil Hcl	156	26
Temazepam	Temazepam	154	18
Methylprednisolone	Methylprednisolone	147	102
Clonazepam	Clonazepam	146	19
Metoprolol Tartrate	Metoprolol Tartrate	142	32
Allopurinol	Allopurinol	141	32
Januvia	Sitagliptin Phosphate	126	21
Doxycycline Hyclate	Doxycycline Hyclate	125	88
Glimepiride	Glimepiride	122	23
Sertraline Hcl	Sertraline Hcl	121	26
Prednisone	Prednisone	117	21
Ezetimibe	Ezetimibe	110	25
Simvastatin	Simvastatin	108	28
Paroxetine Hcl	Paroxetine Hcl	100	17
Ropinirole Hcl	Ropinirole Hcl	100	16
Famotidine	Famotidine	99	24
Lorazepam	Lorazepam	98	21
Celecoxib	Celecoxib	96	19
Tramadol Hcl	Tramadol Hcl	94	26
Jardiance	Empagliflozin	93	14
Atenolol	Atenolol	90	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	90	23
Synthroid	Levothyroxine Sodium	88	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	86	21
Albuterol Sulfate Hfa	Albuterol Sulfate	82	32
Clopidogrel	Clopidogrel Bisulfate	82	23
Amitriptyline Hcl	Amitriptyline Hcl	75	12
Myrbetriq	Mirabegron	75	16
Levofloxacin	Levofloxacin	71	51
Meclizine Hcl	Meclizine Hcl	71	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	17
Estradiol	Estradiol	70	21
Venlafaxine Hcl Er	Venlafaxine Hcl	70	14
Spironolactone	Spironolactone	68	16
Tizanidine Hcl	Tizanidine Hcl	68	11
Diazepam	Diazepam	67	suppressed
Alendronate Sodium	Alendronate Sodium	66	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	65	51
Oxybutynin Chloride Er	Oxybutynin Chloride	63	16
Prazosin Hcl	Prazosin Hcl	63	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	14
Clonidine Hcl	Clonidine Hcl	59	16
Fluoxetine Hcl	Fluoxetine Hcl	56	11
Fluconazole	Fluconazole	52	30
Cefuroxime	Cefuroxime Axetil	51	44
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	14
Triamcinolone Acetonide	Triamcinolone Acetonide	48	36
Cefdinir	Cefdinir	47	36
Citalopram Hbr	Citalopram Hydrobromide	47	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	11
Mirtazapine	Mirtazapine	46	suppressed
Doxepin Hcl	Doxepin Hcl	44	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	43	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Cholestyramine	Cholestyramine (With Sugar)	41	11
Lansoprazole	Lansoprazole	41	suppressed
Valsartan	Valsartan	41	suppressed
Verapamil Er	Verapamil Hcl	41	11
Methocarbamol	Methocarbamol	40	20
Premarin	Estrogens, Conjugated	40	suppressed
Metformin Hcl Er	Metformin Hcl	39	suppressed
Ramipril	Ramipril	38	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Mounjaro	Tirzepatide	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Bumetanide	Bumetanide	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Linzess	Linaclotide	34	suppressed
Ondansetron Odt	Ondansetron	34	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	28
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	24
Amoxicillin	Amoxicillin	31	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Sotalol	Sotalol Hcl	31	suppressed
Glipizide Er	Glipizide	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Trimethoprim	Trimethoprim	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	17
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	27	suppressed
Promethazine Hcl	Promethazine Hcl	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Terbinafine Hcl	Terbinafine Hcl	26	12
Fenofibrate	Fenofibrate	25	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	25	suppressed
Nystatin	Nystatin	25	19
Terazosin Hcl	Terazosin Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cephalexin	Cephalexin	24	21
Levetiracetam	Levetiracetam	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Cartia Xt	Diltiazem Hcl	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Levemir Flexpen	Insulin Detemir	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Diltiazem 24hr Er	Diltiazem Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Finasteride	Finasteride	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Dilt-Xr	Diltiazem Hcl	18	suppressed
Dutasteride	Dutasteride	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Naproxen	Naproxen	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Primidone	Primidone	18	suppressed
Folic Acid	Folic Acid	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Constulose	Lactulose	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Topiramate	Topiramate	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Brilinta	Ticagrelor	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Indapamide	Indapamide	13	suppressed
Fentanyl	Fentanyl	12	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Propafenone Hcl	Propafenone Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Torsemide	Torsemide	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$96.83 · 5 records	Sumitomo Pharma America, Inc.	GEMTESA, JARDIANCE, NURTEC ODT, ZAVZPRET	5	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error